Assay Design and Optimisation

BioGene is pleased to offer existing and new customers access to its assay design pipeline and In Silico PCR modelling and bioinformatics facilities, for either contract research or simply customer support for those purchasing the QuRapID-XF technology.

Our associate company BG Research possesses the necessary in-house facilities and expertise to design and develop assays specific to your application. The team is made up of a focused group of PhD molecular biologists that have been working with end users since 2004 to design new assays and adapt existing ones in accordance to their defined user requirements.

Assay Design and Optimisation
Assay Design and Optimisation

With the release of the QuRapID-XF we are excited to be able to assist new users to port their existing assays to this new innovative technology, or to truly maximise the advantages of this service, to design new assays De Novo.

We have particular expertise in RT-qPCR from crude samples, heterogenic viruses, multiplexing, point of care in-field detection, neglected tropical diseases and the design of highly sensitive and specific assays.

The team has successfully completed a broad range of pioneering and challenging projects including point of care Ebola and Foot & Mouth assays for key stakeholders. Our success comes from our in-house expertise and ability to translate customer requirements into bespoke and novel solutions to solve customer-centric problems.

Assay Design and Optimisation

All designs are performed to specific documented user requirements which as part of the service we help to define and remain traceable throughout the product realization process.

BG Research is an ISO 13485 company certified company registered with the British Standards Institute (BSI). As a result our implemented ISO 13485 Quality Management System ensures quality assurance and risk management are at the forefront of our assay product realization process.

We can assist in transferring your designed assay from design and development to production and market release including regulatory approval. As part of this process we have established partners across Europe with BSL 3 & 4 testing facilities which can be used for external validation.

Please contact us to discuss your requirements and find out how we can provide the solution.

Assay Design and Optimisation
Assay Design and Optimisation